-
ILCA 2024 | Dr. Lin Zhang: New Perspectives in Liver Cancer Treatment – The Impact of Immune Microenvironment on SIRT Efficacy
Selective Internal Radiation Therapy (SIRT) is a validated treatment for liver cancer, yet the influence of the immune microenvironment on treatment response and survival remains unclear. At the 18th International Liver Cancer Association (ILCA) Annual Conference, a recent study shed light on the complex relationship between the immune microenvironment in liver cancer patients prior to…
-
Dr. Jie Xu: Advancing Empirical Treatment Strategies for Febrile Neutropenia
Febrile neutropenia is a significant concern among immunocompromised patients due to the high infection-related mortality if left untreated. At the recent 4th Shanghai Symposium on Clinical Application of Autologous Hematopoietic Stem Cell Transplantation, Dr. Jie Xu of Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, discussed new empirical treatment approaches. This article consolidates…
-
Chairman’s Interview | Dr. Shuangsuo Dang: Ten Years on the Road, Exploring New Trends in Hepatology in the Western Regions
Hepatology Digest: This is the 10th “Silk Road Hepatology” Academic Conference. Could you take us through the journey of the past ten years? Dr. Shuangsuo Dang: The “Silk Road Hepatology”…
-
Dr. Tao Chen: Insights on the “Expert Consensus on Thymosin Alpha-1 in Infectious Diseases and Critical Illness” | CCIFLDI 2024
Overview of Thymosin Alpha-1 (Tα1) Thymosin Alpha-1 (Tα1), also known as thymic peptide α1, was initially isolated from calf thymus and is expressed in humans with an identical sequence. Tα1…
-
IHPBA President | Prof. René Adam and Academician Xiaoping Chen：Strengthening Friendships and Enhancing Cooperation – Expanding the Vision of the International Hepato-Pancreato-Biliary Association (IHPBA) in China
From October 25 to 28, 2024, Wuhan hosted an enriching academic exchange – the 9th Academic Symposium of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (CCIHPBA), alongside the symposium commemorating the 110th birth anniversary of Academician Fazu Qiu and a tribute to Academician Yunyi Liu. Oncology Frontier, invited Prof. René Adam, current President of…
-
PNAS丨Dr. Wenshi Wang’s Team from Xuzhou Medical University Unveils Key Molecular Mechanisms of Cross-Species Transmission of Rat HEV
Since 2018, however, cases of human infections by rat HEV (HEV-C1) causing viral hepatitis have been reported in various countries, with increasing frequency. Notably, two pediatric cases of unexplained acute…
-
The 2024 Jiangsu Hematology Physicians Association Conference Highlights Advancements in Standardized Diagnosis and Treatment of Hematologic diseases
From October 18 to 20, 2024, the 2024 Jiangsu Hematology Physicians Association Academic Conference was held in Taizhou, Jiangsu Province, focusing on the standardized diagnosis and treatment of hematologic diseases. Organized by the Jiangsu Hematology Physicians Association and hosted by the Affiliated Taizhou People’s Hospital of Nanjing Medical University and The First Affiliated Hospital of…
-
ESMO 2024| Dr. Zhen Cai: Progress in Immunotherapy for Multiple Myeloma and New Perspectives on MRD Detection
CAR-T therapy and bispecific antibodies, two innovative immunotherapies, have shown significant efficacy in patients with relapsed/refractory multiple myeloma (RRMM). But how do these two therapies compare in clinical practice? Minimal Residual Disease (MRD) detection is an important tool for evaluating treatment response and prognosis in multiple myeloma (MM), but its application in clinical settings is…
Connecting Medical Expertise through Media